Abstract:ALI (Acute lung injury, ALI) is an acute progressive dyspnea and refractory hypoxemia caused by a variety of internal and external pulmonary factors. Inflammation and destruction of alveolar-capillary barrier are the main pathological characters of ALI, in which endothelial injury of microcirculation is the hallmark. Mobilizing from bone marrow, EPC (endothelial progenitor cell, EPC) can migrate towards the sites of vascular injuries and differentiate into mature endothelium to play a direct repair role and improve microenvironment through indirect immunomodulation. In addition , EPC also secrete cytokines that promote angiogenesis in an autocrine or paracrine manner. Thereby, alleviating organ dysfunction. This article is dedicated to describe the application of EPC in ALI to provide new insight for treatment of ALI.